TIRANA, Dec 6 /ATA/ –By I. Vata/ The Council of Ministers’ decision on a medicine reimbursement scheme for all COVID-19 patients receiving treatment at home was transliterated on Sunday.
According to the instruction dated November 19, only people who have tested positive for COVID-19, confirmed by the responsible public health institutions, will benefit from this scheme.
According to the document, the COVID-19 patients suffering mild symptoms of the disease will receive treatment at home and will benefit a compensation ranging from 1650 to 10 900 lek under the medicine and vitamin reimbursement scheme.
Based on this order, the protocol of treating COVID-19 at home is unveiled. The treatment for the patients showing mild COVID-19 symptoms includes, Paracetamol, Aspirin, Ibuprofen, Vitamin C and D, Azithromycin, Levofloxacin.
For patients showing moderate symptoms, the treatment also includes Azithromycin 250 mg, Levofloxacin 500mg, Vitamins, Dexamethasone 0.5 mg, Apixaban 5 mg, Rivaroxaban 15 mg. The last two anticoagulants are used only if the patients suffer from underlying conditions.
The two treatment protocols will include free medication for one month only.
The family doctor, after deciding about the category Sars-cov 2 as well as the diagnosis of COVID-19, the mild and moderate symptoms according to the instruction on home treatment of COVID-19 infection cases will provide the prescription of the drugs as defined in the instruction. The maximum duration of treatment will be no more than 1 month and will not exceed the reimbursement value determined by the decision of the Council of Ministers
/u.sh/
